52320-59-9 Usage
Description
5-Ethyl-isoxazole-3-carboxylic acid, a chemical compound with the molecular formula C7H9NO3, is a derivative of isoxazole that features a carboxylic acid group. It is recognized for its versatility in organic synthesis and serves as a crucial building block in the development of new pharmaceuticals.
Uses
Used in Pharmaceutical Research:
5-Ethyl-isoxazole-3-carboxylic acid is utilized as a starting material for the synthesis of various drug candidates and biologically active compounds. Its unique structure and functional groups make it a valuable component in the creation of novel therapeutic agents.
Used in Organic Synthesis:
As a versatile intermediate, 5-Ethyl-isoxazole-3-carboxylic acid is employed in the organic synthesis of a wide range of chemical products, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Antimicrobial Applications:
5-Ethyl-isoxazole-3-carboxylic acid has been studied for its potential antimicrobial properties, making it a candidate for use in the development of new antimicrobial agents to combat resistant strains of bacteria.
Used in Anti-inflammatory Applications:
5-ETHYL-ISOXAZOLE-3-CARBOXYLIC ACID has also been investigated for its anti-inflammatory properties, suggesting its potential use in the development of anti-inflammatory drugs to treat various inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 52320-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,2 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52320-59:
(7*5)+(6*2)+(5*3)+(4*2)+(3*0)+(2*5)+(1*9)=89
89 % 10 = 9
So 52320-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H7NO3/c1-2-4-3-5(6(8)9)7-10-4/h3H,2H2,1H3,(H,8,9)
52320-59-9Relevant articles and documents
SUBSTITUTED PIPERIDINE COMPOUNDS
-
Paragraph 0360, (2016/06/01)
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i
Isoxazole derivatives
-
, (2008/06/13)
Isoxazole derivatives represented by the formula: STR1 are prepared; wherein R1 and R2 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, or cycloalkyl group of 3 to 10 carbon atoms; R3 and R4 each is hydrogen atom, alkyl group of 1 to 8 carbon atoms, cycloalkyl group of 3 to 10 carbon atoms, or phenyl group; or the group Is morpholino group; and Y is oxo group, thioxo group or imino group; being useful as a hypoglycemic and/or a blood free-fatty-acid normalizing antidiabetic agent.